Return On Assets of Insight Molecular Diagnostics Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Insight Molecular Diagnostics Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Insight Molecular Diagnostics Inc. Return On Assets for the quarter ending 30 Sep 2025 was -128%, a 116% decline year-over-year.
  • Insight Molecular Diagnostics Inc. annual Return On Assets for 2024 was -97%, a 184% decline from 2023.
  • Insight Molecular Diagnostics Inc. annual Return On Assets for 2023 was -34%, a 33% increase from 2022.
  • Insight Molecular Diagnostics Inc. annual Return On Assets for 2022 was -51%, a 26% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Insight Molecular Diagnostics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -128% -69% -116% 01 Jul 2025 30 Sep 2025
Q2 2025 -117% -70% -145% 01 Apr 2025 30 Jun 2025
Q1 2025 -97% -46% -91% 01 Jan 2025 31 Mar 2025
Q4 2024 -97% -63% -184% 01 Oct 2024 31 Dec 2024
Q3 2024 -59% +5% +8% 01 Jul 2024 30 Sep 2024
Q2 2024 -48% +8% +14% 01 Apr 2024 30 Jun 2024
Q1 2024 -51% -4% -8.8% 01 Jan 2024 31 Mar 2024
Q4 2023 -34% +17% +33% 01 Oct 2023 31 Dec 2023
Q3 2023 -65% -24% -60% 01 Jul 2023 30 Sep 2023
Q2 2023 -56% -13% -32% 01 Apr 2023 30 Jun 2023
Q1 2023 -47% -3% -7.7% 01 Jan 2023 31 Mar 2023
Q4 2022 -51% -10% -26% 01 Oct 2022 31 Dec 2022
Q3 2022 -40% -14% -55% 01 Jul 2022 30 Sep 2022
Q2 2022 -42% -16% -62% 01 Apr 2022 30 Jun 2022
Q1 2022 -43% -9% -27% 01 Jan 2022 31 Mar 2022
Q4 2021 -40% +10% +20% 01 Oct 2021 31 Dec 2021
Q3 2021 -26% +31% +55% 01 Jul 2021 30 Sep 2021
Q2 2021 -26% +35% +57% 01 Apr 2021 30 Jun 2021
Q1 2021 -34% +28% +45% 01 Jan 2021 31 Mar 2021
Q4 2020 -51% +8% +14% 01 Oct 2020 31 Dec 2020
Q3 2020 -57% +5% +8.2% 01 Jul 2020 30 Sep 2020
Q2 2020 -61% +4% +6.6% 01 Apr 2020 30 Jun 2020
Q1 2020 -62% +21% +25% 01 Jan 2020 31 Mar 2020
Q4 2019 -59% +67% +53% 01 Oct 2019 31 Dec 2019
Q3 2019 -62% +57% +48% 01 Jul 2019 30 Sep 2019
Q2 2019 -66% +81% +55% 01 Apr 2019 30 Jun 2019
Q1 2019 -83% +58% +41% 01 Jan 2019 31 Mar 2019
Q4 2018 -126% +24% +16% 01 Oct 2018 31 Dec 2018
Q3 2018 -120% +13% +9.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -147% -50% -51% 01 Apr 2018 30 Jun 2018
Q1 2018 -141% -45% -47% 01 Jan 2018 31 Mar 2018
Q4 2017 -150% -57% -62% 01 Oct 2017 31 Dec 2017
Q3 2017 -132% -33% -33% 01 Jul 2017 30 Sep 2017
Q2 2017 -97% 01 Apr 2017 30 Jun 2017
Q1 2017 -96% 01 Jan 2017 31 Mar 2017
Q4 2016 -92% 01 Oct 2016 31 Dec 2016
Q3 2016 -99% 01 Jul 2016 30 Sep 2016

Insight Molecular Diagnostics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -97% -63% -184% 01 Jan 2024 31 Dec 2024
2023 -34% +17% +33% 01 Jan 2023 31 Dec 2023
2022 -51% -10% -26% 01 Jan 2022 31 Dec 2022
2021 -40% +10% +20% 01 Jan 2021 31 Dec 2021
2020 -51% +8% +14% 01 Jan 2020 31 Dec 2020
2019 -59% +67% +53% 01 Jan 2019 31 Dec 2019
2018 -126% +24% +16% 01 Jan 2018 31 Dec 2018
2017 -150% -57% -62% 01 Jan 2017 31 Dec 2017
2016 -92% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.